搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
13 天
Alto Neuroscience股票获买入评级,临床试验前景乐观
周二,TD Cowen维持对Alto Neuroscience(纽约证券交易所代码:ANRO)股票的买入评级,对该公司即将公布的临床试验结果表示信心。该机构的乐观情绪源于Alto Neuroscience最近举行的投资者关系活动,公司在活动中详细介绍了其针对重度抑郁障碍(MDD)治疗的2b期临床试验的设计和目标。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Left note, bail denied
1951 kidnap victim found
Daylight saving time
Didn't authorize apology
Astronauts return to Earth
San Francisco homelessness
Visits US ammunition plant
Donlon's homes searched
Reds fire manager
Economic speech this week
Tech ban proposed
Gulf Coast storm warning
No govt. shutdown for now
No. 1 at box office again
To meet Vietnamese pres
Iran coal mine blast
SpaceX plans Mars missions
Free COVID-19 tests
Robinson loses key staff
Dolphins legend Morris dies
Makes new offer to union
Closing last full-size store
NE electoral change blocked
California sues ExxonMobil
FBI: Violent crime declined
Returning Indian antiquities
Colo. shooter found guilty
Makes emergency landing
Co-founder testifies
More troops to Middle East
反馈